Notably, these miRNAs showed significant correlations with clinical parameters, such as ALT, and uric acid levels and TyG-based insulin resistance indices, suggesting their involvement in hepatic injury and metabolic dysregulation. This evidence concerns the gene GPT and Insulin resistance.